Sage Journals: Discover world-class research

Open access

Research article

First published 2026-6

Intranasal Application of Ubrogepant Nanoparticles Improve the Brain Penetration and Efficacy in Migraine

Vignesh Mohan, Anil M. Pethe

Journal of Pharmacology and Pharmacotherapeutics

Open access

Research article

First published 2020-8

Ubrogepant does not induce latent sensitization in a preclinical model of medication overuse headache

Edita Navratilova, Sasan Behravesh, Janice Oyarzo [...]

Cephalalgia

Open access

Research article

First published 2026-6

A Nasal Gel Formulation of Ubrogepant Nanoparticles for Enhanced and Rapid Brain Delivery in the Treatment of Migraine

Vignesh Mohan, Anil Meghrajji Pethe

Journal of Pharmacology and Pharmacotherapeutics

Free access

Research article

First published 2016-8

A phase IIb randomized,double-blind,placebo-controlled trial of ubrogepant for the acute treatment of migraine

Tiffini Voss, Richard B Lipton, David W Dodick [...]

Cephalalgia

Open access

Research article

First published 2020

Evaluation of the pharmacokinetic interaction and safety of ubrogepant coadministered with acetaminophen or nonsteroidal anti-inflammatory drugs: A randomized trial

Abhijeet Jakate, Ramesh Boinpally, Matthew Butler [...]

Cephalalgia Reports

Retricted access

Review article

First published 2022-3

Ubrogepant: An Oral Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonist for Abortive Migraine Treatment

Madell Nedd, Scott Garland, Nathan Falk [...]

Annals of Pharmacotherapy

Open access

Research article

First published 2020

The effect of multiple doses of ubrogepant on the pharmacokinetics of an oral contraceptive in healthy women: Results of an open-label,single-center,two-period,fixed-sequence study

Chi-Chung Li, John Palcza, Jialin Xu [...]

Cephalalgia Reports

Free access

Research article

First published 2022-1

Doubtful use of placebo following placebo in recent controlled trials of lasmiditan and ubrogepant for the treatment of migraine attacks

Peer Tfelt-Hansen, Karsten Jørgensen, Hans-Christoph Diener

Cephalalgia

Open access

Research article

First published 2021

Effects of CYP3A4 and P-glycoprotein inhibition or induction on the pharmacokinetics of ubrogepant in healthy adults: Two phase 1,open-label,fixed-sequence,single-center,crossover trials

Abhijeet Jakate, Ramesh Boinpally, Matthew Butler [...]

Cephalalgia Reports

Open access

Research article

First published 2019-12

Safety and tolerability of ubrogepant following intermittent,high-frequency dosing: Randomized,placebo-controlled trial in healthy adults

Peter J Goadsby, Stewart J Tepper, Paul B Watkins [...]

Cephalalgia

Search results